Remifentanil was designed to serve as a strong anesthetic with an ultra-short and predictable duration that would not have accumulation issues. Remifentanil is patented by Glaxo Wellcome Inc. and was FDA approved on July 12, 1996. Pricing for Ultiva. 1 mg vial - 30.19 USD; 3 mg vial - 57.20 USD; 5 mg vial - 118.15 USD
Breach of contract is a legal cause of action in which a binding agreement or bargained-for exchange is not honored by one or more of the parties to the contract by non-performance or interference with the other party's performance.
Other damages for breach of a binding contract do exist, however. In some cases, the court will command specific performance. This means the defendant who breached the contract will be legally compelled by the court to fulfill his part of the bargain.